Erin Sweet

551 total citations
23 papers, 433 citations indexed

About

Erin Sweet is a scholar working on Complementary and alternative medicine, Oncology and Pharmacology. According to data from OpenAlex, Erin Sweet has authored 23 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Complementary and alternative medicine, 12 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Erin Sweet's work include Complementary and Alternative Medicine Studies (13 papers), Cancer survivorship and care (10 papers) and Herbal Medicine Research Studies (4 papers). Erin Sweet is often cited by papers focused on Complementary and Alternative Medicine Studies (13 papers), Cancer survivorship and care (10 papers) and Herbal Medicine Research Studies (4 papers). Erin Sweet collaborates with scholars based in United States, Canada and Spain. Erin Sweet's co-authors include Leanna J. Standish, M. Robyn Andersen, Carolyn J. Torkelson, Cynthia A. Wenner, Mark R. Martzen, Carly A. Bridge, Ana Nelson, Jeffrey P. Novack, Barbara A. Goff and Frederick Dowd and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gynecologic Oncology and Psycho-Oncology.

In The Last Decade

Erin Sweet

23 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin Sweet United States 12 156 146 97 72 50 23 433
Seong Woo Yoon South Korea 13 119 0.8× 133 0.9× 71 0.7× 119 1.7× 25 0.5× 38 531
Stefania Milazzo Australia 13 105 0.7× 112 0.8× 39 0.4× 62 0.9× 42 0.8× 21 537
Oluwadamilola Olaku United States 8 197 1.3× 60 0.4× 47 0.5× 80 1.1× 9 0.2× 11 395
Matthias Kröz Germany 11 98 0.6× 48 0.3× 24 0.2× 73 1.0× 86 1.7× 35 384
Yifang Chen China 11 68 0.4× 40 0.3× 34 0.4× 139 1.9× 36 0.7× 23 505
Dan Labriola Italy 5 212 1.4× 66 0.5× 16 0.2× 32 0.4× 11 0.2× 8 367
Zhihao Zhang China 13 58 0.4× 30 0.2× 64 0.7× 286 4.0× 42 0.8× 27 640
Ramin Nasimi Doost Azgomi Iran 10 102 0.7× 22 0.2× 28 0.3× 59 0.8× 26 0.5× 26 392
Ahmet Musmul Türkiye 12 25 0.2× 36 0.2× 42 0.4× 79 1.1× 33 0.7× 58 469
C. Hutchison United Kingdom 11 219 1.4× 55 0.4× 132 1.4× 80 1.1× 8 0.2× 20 572

Countries citing papers authored by Erin Sweet

Since Specialization
Citations

This map shows the geographic impact of Erin Sweet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Sweet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Sweet more than expected).

Fields of papers citing papers by Erin Sweet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Sweet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Sweet. The network helps show where Erin Sweet may publish in the future.

Co-authorship network of co-authors of Erin Sweet

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Sweet. A scholar is included among the top collaborators of Erin Sweet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Sweet. Erin Sweet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seely, Dugald, Erin Sweet, J. T. Ennis, et al.. (2025). A Comprehensive Description of Naturopathic Care for Advanced Cancers: Outcomes from the Canadian/US Integrative Oncology Study. 32(2). 21–40. 1 indexed citations
2.
Solodiuk, Jean C., et al.. (2022). Weaning Dexmedetomidine in Non-ICU Areas: An Implementation Effort. Pediatric Critical Care Medicine. 23(5). 353–360. 3 indexed citations
3.
Standish, Leanna J., Erin Sweet, Eun-Jung Kim, et al.. (2021). Recurrence of Breast Cancer After Primary Treatment: A Matched Comparison Study of Disease-Free Survival in Women Who Do and Do Not Receive Adjunctive Naturopathic Oncology Care. Integrative Cancer Therapies. 20. 1543373540–1543373540. 2 indexed citations
4.
Andersen, M. Robyn, et al.. (2019). Effects of Vitamin D Use on Health-Related Quality of Life of Breast Cancer Patients in Early Survivorship. Integrative Cancer Therapies. 18. 1870040488–1870040488. 13 indexed citations
5.
Sweet, Erin, et al.. (2018). Nurse Practitioner-Administered Chloroprocaine in Children with Postoperative Pain. Pain Management Nursing. 19(4). 424–429. 1 indexed citations
6.
Standish, Leanna J., et al.. (2018). Do Women With Breast Cancer Who Choose Adjunctive Integrative Oncology Care Receive Different Standard Oncologic Treatment?. Integrative Cancer Therapies. 17(3). 874–884. 7 indexed citations
7.
Andersen, M. Robyn, et al.. (2018). Use of Integrative Oncology, Involvement in Decision-Making, and Breast Cancer Survivor Health-Related Quality of Life in the First 5 Years Postdiagnosis. Integrative Cancer Therapies. 17(3). 636–645. 12 indexed citations
8.
Sweet, Erin, et al.. (2016). The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy. Evidence-based Complementary and Alternative Medicine. 2016(1). 4382687–4382687. 20 indexed citations
9.
Standish, Leanna J., et al.. (2016). Breast Cancer Integrative Oncology Care and Its Costs. Integrative Cancer Therapies. 16(1). 85–95. 21 indexed citations
10.
Andersen, M. Robyn, et al.. (2015). The ‘cause’ of my cancer, beliefs about cause among breast cancer patients and survivors who do and do not seek IO care. Psycho-Oncology. 26(2). 248–254. 10 indexed citations
11.
Andersen, M. Robyn, et al.. (2014). Complementary and Alternative Medicine Use by Breast Cancer Patients at Time of Surgery Which Increases the Potential for Excessive Bleeding. Integrative Cancer Therapies. 14(2). 119–124. 12 indexed citations
12.
Andersen, M. Robyn, Erin Sweet, Kimberly A. Lowe, et al.. (2013). Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer. The Journal of Alternative and Complementary Medicine. 19(8). 714–720. 27 indexed citations
13.
Sweet, Erin, Leanna J. Standish, Barbara A. Goff, & M. Robyn Andersen. (2013). Adverse Events Associated With Complementary and Alternative Medicine Use in Ovarian Cancer Patients. Integrative Cancer Therapies. 12(6). 508–516. 13 indexed citations
14.
Andersen, M. Robyn, Erin Sweet, Kimberly A. Lowe, et al.. (2012). Potentially Dangerous Complementary and Alternative Medicine (CAM) Use by Ovarian Cancer Patients. Journal of Gynecologic Surgery. 28(2). 116–120. 4 indexed citations
15.
Lowe, Kimberly A., M. Robyn Andersen, Erin Sweet, et al.. (2012). The Effect of Regular Exercise and Yoga on Health-Related Quality of Life Among Ovarian Cancer Survivors. Journal of Evidence-Based Complementary & Alternative Medicine. 17(3). 155–160. 3 indexed citations
16.
Torkelson, Carolyn J., Erin Sweet, Mark R. Martzen, et al.. (2012). Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer. SHILAP Revista de lepidopterología. 2012. 1–7. 52 indexed citations
17.
18.
McDermott, Cara L., et al.. (2011). A Pilot Study of Website Information Regarding Aromatase Inhibitors: Dietary Supplement Interactions. The Journal of Alternative and Complementary Medicine. 17(11). 1043–1049. 7 indexed citations
19.
Andersen, M. Robyn, Erin Sweet, Kimberly A. Lowe, et al.. (2011). Involvement in decision-making about treatment and ovarian cancer survivor quality of life. Gynecologic Oncology. 124(3). 465–470. 35 indexed citations
20.
Standish, Leanna J., Erin Sweet, Jeffrey P. Novack, et al.. (2008). Breast cancer and the immune system.. PubMed. 6(4). 158–68. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seong Woo Yoon Breakdown of academic impact, for papers by Stefania Milazzo Breakdown of academic impact, for papers by Oluwadamilola Olaku Breakdown of academic impact, for papers by Matthias Kröz Breakdown of academic impact, for papers by Yifang Chen Breakdown of academic impact, for papers by Dan Labriola Breakdown of academic impact, for papers by Zhihao Zhang Breakdown of academic impact, for papers by Ramin Nasimi Doost Azgomi Breakdown of academic impact, for papers by Ahmet Musmul Breakdown of academic impact, for papers by C. Hutchison
Rankless by CCL
2026